Immobilized Human TNFRSF10B (1 µg/mL) bind Human TNFSF10 in a functional ELISA with a linear range of 0.1-11.7 ng/mL. Inhibition of the TRAIL-mediated cytotoxicity using L_x001e_929 mouse fibroblast cells treated with TRAIL: ED50 = 30-120 pg/mL in the presence of 20 ng/mL Recombinant Human TRAIL/TNFSF10.
Purity
>95% (by SDS-PAGE).
Product Form
Lyophilized
Concentration
Reconstitution dependent.
Formulation
Lyophilized from Phosphate Buffered Saline, pH 7.4 (0.22µm filter sterilized).
Endotoxin Level
<0.1 EU/µg.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C up to 1 year from the date of receipt. Reconstituted: Aliquot and store at -20°C for 3 months or 2-8°C for up to 1 week. Avoid freeze/thaw cycles.
Standard Curve - Recombinant Human DR5 Protein (C-terminal Human Fc and His Tag) (A330550)
ELISA examination of immobilized Human TNFRSF10B (1 µg/mL) binding Recombinant Human DR5 Protein (C-terminal Human Fc and His Tag) (A330550): linear range = 0.1-11.7 ng/mL.
Recombinant Human DR5 Protein (C-terminal Human Fc and His Tag) (A330550)
TRAIL-mediated cytotoxicityin L-929 mouse fibroblast cells treated with TRAIL inhibited by Recombinant Human DR5 Protein (C-terminal Human Fc and His Tag) (A330550): ED50 = 30-120 pg/mL in the presence of 20 ng/mL Recombinant Human TRAIL/TNFSF10.
Publishing research using Recombinant Human DR5 Protein (C-terminal Human Fc and His Tag) (A330550)? Please let us know so that we can list the citation on this page.
Alternative products to Recombinant Human DR5 Protein (C-terminal Human Fc and His Tag) (A330550)